A
Aleš Linhart
Researcher at First Faculty of Medicine, Charles University in Prague
Publications - 371
Citations - 36568
Aleš Linhart is an academic researcher from First Faculty of Medicine, Charles University in Prague. The author has contributed to research in topics: Fabry disease & Medicine. The author has an hindex of 50, co-authored 333 publications receiving 30467 citations. Previous affiliations of Aleš Linhart include University Hospital of Wales & Charles University in Prague.
Papers
More filters
Posted ContentDOI
AGAL misprocessing-induced ER stress and the unfolded protein response: lysosomal storage-independent mechanism of Fabry disease pathogenesis?
Martina Živná,Gabriela Dostálová,Veronika Baresova,Dita Musalkova,Ladislav Kuchar,Befekadu Asfaw,Helena Poupětová,Hana Vlaskova,T. Kmochová,Petr Vylet'al,Hana Hartmannová,Kateřina Hodaňová,Viktor Stránecký,Lenka Steiner-Mrazova,Aleš Hnízda,Martin Radina,Miroslav Votruba,Jana Sovová,Helena Trešlová,Larisa Stolnaja,Petra Reková,Lenka Roblová,Eva Honsova,Helena Hůlková,Ivan Rychlik,Anthony J. Bleyer,Aleš Linhart,Jakub Sikora,Stanislav Kmoch +28 more
TL;DR:
Závažná plicní embolie
TL;DR: Plicni embolie as discussed by the authors is relativně casto se vyskytujici onemocný s nezanedbatelnou mortalitou, nepravem podceňovane, ktere je ale při ======vcasne diagnoze dobře lecitelne, a je-li adekvatni lecba zahajena vcas, býva dob´e ucinna.
Journal ArticleDOI
Alcohol septal ablation for successful treatment of the left ventricular outflow tract obstruction in fabry disease
TL;DR: Fabry disease is an X-linked linked genetic disorder caused by α-galactosidase A deficiency and typical cardiac manifestations include development of hypertrophic cardiomyopathy phenotype (HCM), but some patients with FD develop left ventricular outflow tract.
Akutní infarkt myokardu u mladých nemocných - výsledky pilotního sledování
Gabriela Dostálová,Jan Bělohlávek,Marcela Škvařilová,Tomas Palecek,Kateřina Jirátová,Vratislav Mrazek,Michael Aschermann,Aleš Linhart +7 more
TL;DR: AIM (Infarktu myokardu) as mentioned in this paper ) is an AIM that is used for infarkt myokards in the treatment of chronic lung cancer.
Journal ArticleDOI
Kouření a kardiovaskulární onemocnění
Michael Aschermann,Aleš Linhart +1 more
TL;DR: Kouřeni patři k uznavaným rizikový m faktorům aterosklerozy, jeho aktivni i pasivni formy se podileji na iniciaci a progresi aTEROSKlerozy i na rozvoji nestabilnich forem - akutnich koronarnich syndromů as mentioned in this paper.